The clinical spectrum and diagnosis of oxaliplatin liver injury in the era of nonalcoholic fatty liver disease

HP Kim, V Navarro, S Zacks, J Odin… - Clinical …, 2021 - cghjournal.org
Results DILIN's consensus expert opinion diagnosed 1 case as definite (> 95% likelihood), 4
cases as highly likely (75%–95%), and 2 cases as probable (50%–74%). All patients …
被引用次数：6 相关文章

The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease.

HP Kim, V Navarro, S Zacks, J Odin… - … and Hepatology: the …, 2020 - europepmc.org
Methods The Drug-Induced Liver Injury Network (DILIN) inclusion criteria are based on liver
biochemistries. 4 Patients not meeting criteria may enroll, if approved by the Exemptions …
[HTML] nih.gov

[HTML][HTML] The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Non-alcoholic Fatty Liver Disease

HP Kim, V Navarro, S Zacks, J Odin… - … and hepatology: the …, 2021 - ncbi.nlm.nih.gov
Methods The Drug-Induced Liver Injury Network (DILIN) inclusion criteria are based on liver
biochemistries. 4 Patients not meeting criteria may enroll, if approved by the Exemptions …

The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease

HP Kim, V Navarro, S Zacks, J Odin… - … : the official clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Oxaliplatin is an alkylating agent given with fluorouracil and leucovorin as a mainstay
adjuvant chemotherapy for stage III colorectal cancer (CRC). Liver injury from oxaliplatin …

[引用][C] The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty Liver Disease

HP Kim, V Navarro, S Zacks, J Odin… - Clinical …, 2021 - cir.nii.ac.jp
The Clinical Spectrum and Diagnosis of Oxaliplatin Liver Injury in the Era of Nonalcoholic Fatty
Liver Disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …